Bonmax
Presentation:
Each film-coated tablet contains Ibandronate Sodium INN 168.75 mg equivalent to Ibandronic Acid 150mg.
Description:
Ibandronic acid is a highly potent bisphosphonate belonging to the nitrogen-containing group of bisphosphonates. It acts selectively on bone tissue and specifically inhibits osteoclast activity without directly affecting bone formation. Ibandronic acid leads to progressive net gains in bone mass and a decreased incidence of fractures through the reduction of elevated bone turnover towards premenopausal levels in postmenopausal women. The pharmacodynamic action of Ibandronic acid is inhibition of bone resorption
Therapeutic Class: Bisphosphonate.
